Medical News

RSS

Auxilium Pharmaceuticals declares pricing of common stock shares

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced the pricing of a public offering of 3 million shares of its common stock.

26 Sep 2009

Initial clinical results for Mpathy Medical's Omnisure sling released

Mpathy Medical, a rapidly growing medical device company which has developed and brought to market a range of less invasive surgical solutions used to restore pelvic health to women, released the initial clinical results for its newest product, Omnisure™, a novel full length sling for treatment of female stress urinary incontinence (SUI) at the American Urogynecologic Society’s (AUGS) Annual Meeting.

26 Sep 2009

PureSafety's OHM solutions at Salem Hospital

Salem Hospital, a 464-acute care non-profit hospital that operates the busiest emergency department in Oregon, has partnered with PureSafety to utilize the company’s Occupational Health Manager® (OHM) solutions to streamline the hospital’s occupational health and medical management processes.

26 Sep 2009

G-bor Bal-zsi's innovative research in drug resistance earns select honor

A unique approach to understanding how cells develop resistance to drugs has won a scientist at The University of Texas M. D. Anderson Cancer Center a New Innovator Award from the National Institutes of Health.

26 Sep 2009

Symposium on ways to lower preterm birth rate

Journalists are invited to attend a gathering of the nation's leading maternal-child and quality assurance health care experts who will review and develop programs that may help lower the nation's costly preterm birth rate.

26 Sep 2009

Cardiome Pharma to extend the term of its "Dutch Auction" tender offer

Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) ("Cardiome" or the "Company") announced that it will extend the term of its modified "Dutch Auction" tender offer (the "Offer") for up to US$27.5 million of its common shares commenced on September 1, 2009.

26 Sep 2009

House Dems consider taxing insurers for high-premium plans

In the House, Democrats are considering levying a tax on insurance companies for providing high-premium plans. In the Senate, the Finance Committee has recessed before considering the public option.

26 Sep 2009

Gates Foundation launches campaign to highlight U.S. global health investment successes

The Bill & Melinda Gates Foundation on Thursday announced the launch of the Living Proof Project that aims to highlight how U.S. foreign aid contributes to improving global health, the Associated Press reports. Bill Gates said in a statement, "We want to show Americans that their investments in global health are working" (Pace, 9/24).

26 Sep 2009

Accelr8 Technology concludes technical development project with Becton

Accelr8 Technology Corporation announced today that it has concluded a technical development project with Becton, Dickinson and Company (“BD”) (NYSE: BDX).

26 Sep 2009

Intervention program helps children live healthier lives: Study

A new Iowa State University study found that a family, school and community intervention program helps children live healthier lives and could be a new tool in the fight against the nation's childhood obesity epidemic.

26 Sep 2009

Virginia Tech student granted fellowship for research study on LaCrosse Virus disease

Camille Harris of Ridgeland, Mississippi, a graduate student in biological sciences at Virginia Tech, has been awarded a National Institutes of Health (NIH) Graduate Research Fellowship for her study of forest disturbance and its ecological impacts on LaCrosse Virus, a mosquito-borne disease that can cause seizures, coma, paralysis, and permanent brain damage in severe cases.

26 Sep 2009

Research study sheds light on mechanisms of pain alteration in infancy and adolescence

Scientists at Georgia State University have uncovered the mechanisms of how pain in infancy alters how the brain processes pain in adulthood.

26 Sep 2009

Stem Cell Therapy International merges with Histostem

Stem Cell Therapy International, Inc. is proud to announce the execution of the Reorganization and Stock Purchase Agreement ("the Agreement") with Histostem Co., Ltd., a Korean company ("Histostem" and together with SCII, "the parties").

25 Sep 2009

Researchers discover potential treatment for Friedreich's ataxia

Using clever chemistry, a Scripps Research team has pinpointed the enzyme target of a drug group that stops the progression of the devastating disease Friedreich's ataxia in mice and may do the same for humans. The findings, developed in collaboration with scientists from Repligen Corporation, help advance this treatment approach one step closer toward human clinical trials, which will be a welcome event for disease sufferers who currently have few treatment options.

25 Sep 2009

Central metabolic network model of Thermotoga maritima bacterium developed

Investigators at Burnham Institute for Medical Research (Burnham), University of California, San Diego (UC San Diego), The Scripps Research Institute (TSRI), Genomics Institute of the Novartis Research Foundation (GNF) and other institutions have constructed a complete model, including three dimensional protein structures, of the central metabolic network of the bacterium Thermotoga maritima (T. maritima).

25 Sep 2009

RWJF Nursing Scholarship Program helps alleviate nation's nursing shortage

Loyola University Chicago Marcella Niehoff School of Nursing (MNSON) has been awarded Robert Wood Johnson Foundation (RWJF) funding through the RWJF New Careers in Nursing Scholarship Program.

25 Sep 2009

HORIZONS-AMI clinical trial demonstrates efficacy of drug-eluting stent

Late-breaking data from the landmark HORIZONS-AMI clinical trial, presented at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, demonstrated that after two years, in heart attack patients, the use of a drug-eluting stent (paclitaxel) was safer and more effective than a bare-metal stent; and that the administration of the anticoagulant medication bivalirudin enhanced safety and efficacy compared to the use of heparin + GPIIb/IIIa inhibitors.

25 Sep 2009

Stelara approved by the FDA for treating psoriasis

The U.S. Food and Drug Administration today approved Stelara (ustekinumab), a biologic product for adults who have a moderate to severe form of psoriasis.

25 Sep 2009

Androgen deficiency linked to diabetes and cardiovascular diseases

Researchers from Boston University School of Medicine (BUSM) in collaboration with researchers from Lahey Clinic Northshore, Peabody, Mass., believe that androgen deficiency might be the underlying cause for a variety of common clinical conditions, including diabetes, erectile dysfunction, metabolic syndrome and cardiovascular disease (CVD). These findings appear in the September/October issue of the Journal of Andrology.

25 Sep 2009

New line of household disinfectant wipes and sprays launched

Seventh Generation, the nation's leading brand of non-toxic, environmentally safe household solutions, incorporates the latest breakthrough in green chemistry with the introduction of a new line of household disinfectant wipes and sprays.

25 Sep 2009